PharmaCyte Biotech Inc (PMCB)

[DragonBear]

No one is going to pursue a CiaB type trial only to be sued for IP infringement.

PMCB has a license from an expired patent. No one will pursue a CIAB like trial, because the concept is already 30 yrs old, and has been superseded by targeted therapies.

This is a biologic and it will be evaluated by CBER.

What decade? Where's the IND?

PMCB has filed a provisional on the full CiaB pancreatic cancer treatment.

Full? The expired Austrianova patent covered such a full use.

That is not a refiling. The Austrianova patents that have lapsed were for the old encapsulation process.

Sure it's a refiling. Kenny claims a provisional filing, which can't be confirmed. So what improvement did PMCB make, so as to make PMCB a patent holder of a new CIAB product? What did Kenny tell the SHs? Answer: Nothing.

The latest Austrianova filing is for a new encapsulation process that can withstand stomach acid.

Exactly. Austrianova is filing for a patent they will own. Covering a new delivery system to protect probiotics, and drugs against stomach acid degradation. They have the option after obtaining a patent to license it out to whomever they wish.

One has Kenny claiming a provisional filing on an expired Austrianova patent, PMCB previously licensed from Austrianova. As the filer, PMCB would need to describe the improvements they made to the old CIAB.

In the background one has Austrianova applying for a new encapsulation CIAB like device to protect delivery of probiotics, or drugs from stomach acid.

You suggest these new patents by Austrianova are of relevance to PMCB. So where's the announcement Austrianova has licensed off the new patents to PMCB? And why the provisional filing by Kenny for what?

Also, note the FDA would require new pre-clinical safety studies for a new delivery device. Especially when developed by Austrianova for an unrelated purpose.

Finally, I completely fail to see how a renown doctor such as Dr. Manuel Hidalgo would waste his valuable time with PMCB if everything were as gloomy and futile as you suggest.

Why wouldn't he accept money for his services? Or more accurately for the use of his name?

The market is placing a value on $PMCB of $50+ Million. Further, based on the new S-3, someone is considering a new $50 Million investment.

The market cap for this Microcrap scam is whatever retail bids it up to. A S3 merely registers the shares. It does not mean any single entity is going to buy them. It does mean dilution, which I'll leave you to calculate. Hint: It's potentially huge.